Erratum: Kashigar A, Habbous S, Eng L, Irish B, Bissada E, Irish J, Brown D, Gilbert R, Gullane P, Xu W, Huang S-H, Witterick I, Freeman J, O'Sullivan B, Waldron J, Liu G, and Goldstein D. Social environment, secondary smoking exposure, and smoking cessation among head and neck cancer patients. Cancer. 2013;119:27019.

Errata

This article corrects:

  1. Social environment, secondary smoking exposure, and smoking cessation among head and neck cancer patients Volume 119, Issue 15, 2701–2709, Article first published online: 13 June 2013

Due to alignment issues within Table 1, the authors have asked that a corrected table be published. Please find the revised Table 1 below.

The authors regret this error.

Table 1. Clinical, Demographic, and Smoking/Alcohol Characteristics of the Recruited Head and Neck Cancer Population by Smoking Status
  Current SmokersPredictor of Quitting After 1 Year Prior to Diagnosis (Inactive vs Active)Predictors of Having Already Quit at Baseline (Ex- vs Current Smoker)
VariableEx-Smokers Have not restarted (n = 150)Inactive Smokers (n = 73)Active Smokers (n = 72)UnivariateMultivariatecUnivariateMultivariatec
Odds RatioPOdds RatioPOdds RatioPOdds RatioP
  1. Ex-smokers quit smoking at least 1 year prior to diagnosis, active smokers continued to smoke at the time of diagnosis, whereas inactive smokers quit at some time between baseline and follow-up.

  2. a

    Mean with 95% confidence limits presented;

  3. b

    Each odds ratio (95% confidence limit) was reflective of a 10-unit increment;

  4. c

    Adjusted for all variables in table.

Months until follow-upab25.2 (23.6–26.7)24.6 (22.4–26.9)21.4 (19.8–23.0)1.58 (1.06–2.35).022.02 (1.24–3.25).004 
Demographic factors           
Age (y) at diagnosisab64.3 (62.6–65.9)59.6 (57.2–62.0)59.4 (57.2–61.6)1.02 (0.74–1.42) 1.61 (1.27–2.06).00013.71 (2.48–5.55)<.0001
Female32 (21%)11 (15%)9 (12%)1.24 (0.48–3.21) 1.70 (0.92–3.13).093.84 (1.67–8.81).002
Married or common-law125 (83%)50 (68%)39 (54%)1.84 (0.93–3.62).08 3.15 (1.83–5.42)<.00014.28 (1.92–9.53).0004
High school or higher72 (48%)29 (40%)21 (29%)1.60 (0.80–3.20) 1.75 (1.10–2.80).022.12 (1.12–4.01).02
White138 (92%)68 (93%)63 (87%)1.94 (0.62–6.11) 1.23 (0.55–2.75) 
ECOG131 (87%)56 (77%)63 (88%)2.13 (0.88–5.15).09 1.51 (0.79–2.86) 
Social habits           
Number of cigarettes per dayab17.7 (16.0–19.4)17.3 (15.4–19.2)20.4 (18.4–22.3)1.60 (1.04–2.43).03 1.14 (0.89–1.47) 
Number of years smokedab25.3 (23.1–27.5)35.9 (32.8–38.9)41.6 (39.0–44.2)1.50 (0.12–2.00).0071.98 (1.37–2.84).00032.20 (1.78–2.74)<.00013.32 (2.46–4.52)<.0001
Age started smokingab17.9 (17.1–18.6)17.8 (16.5–19.2)15.4 (14.6–16.2)4.08 (1.54–10.8).005 1.84 (1.07–3.19).03 
Never chewed tobacco/betel nut, or smoked cigars, pipe, or marijuana99 (66%)21 (29%)39 (46%)2.93 (1.47–5.82).0024.77 (2.03–11.2).00031.37 (0.85–2.20) 
No. of alcoholic drinks consumed per weekab6.29 (4.00–8.59)6.63 (3.94–9.31)11.8 (8.57–15.0)1.43 (1.06–1.92).021.76 (1.24–2.54).0021.21 (0.98–1.49).07 
Clinical variables           
COPD (no)135 (92%)66 (90%)56 (78%)2.69 (1.03–7.01).04 2.12 (1.01–4.44).04 
Disease site           
Oropharynx52 (35%)15 (21%)25 (35%)1.0   1.0   
Oral cavity36 (24%)23 (31%)21 (29%)1.83 (0.76–4.36) 0.63 (0.34–1.15)   
Larynx38 (25%)20 (27%)16 (22%)2.08 (0.83–5.22)   0.81 (0.44–1.51) 
Other24 (16%)15 (21%)10 (14%)2.50 (0.90–6.97)   0.74 (0.37–1.48)   
Treatment modality           
Primary surgery24 (19%)19 (29%)5 (8%)1.0.04  
Chemoradiation34 (27%)18 (27%)16 (26%)0.30 (0.09–0.98)       
Primary radiation33 (26%)14 (21%)19 (31%)0.19 (0.06–0.65)       
Surgery + chemoradiation16 (12%)5 (8%)11 (18%)0.12 (0.03–0.51)       
Surgery + radiation21 (16%)10 (15%)11 (18%)0.24 (0.07–0.88)       
Stage           
TNM III vs I/II18 (14%)4 (7%)15 (23%)0.40 (0.11–1.50).04 0.69 (0.31–1.54) 
TNM IV vs I/II66 (53%)37 (70%)31 (48%)1.79 (0.75–4.28)   0.71 (0.40–1.27)   

Ancillary